スポンサーリンク
The First Department Of Internal Medicine University Of Occupational And Environmental Health School | 論文
- Efficacy and safety of mizoribine for the treatment of Sjogren's syndrome : a multicenter open-label clinical trial
- Severe skin ulceration associated with Wegener's granulomatosis : successful treatment with hyperbaric oxygen and prostaglandin E_1
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan : one-year outcome of joint destruction (RECONFIRM-2J)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan : one-year clinical outcomes (RECONFIRM-2)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM)
- Induction of hyperadiponectinemia following long-term treatment of patients with rheumatoid arthritis with infliximab (IFX), an anti-TNF-alpha antibody
- Additive combination of actarit and methotrexate in the treatment of refractory rheumatoid arthritis
- Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy : a randomized trial
- Etanercept overcomes P-glycoprotein-induced drug resistance in lymphocytes of patients with intractable rheumatoid arthritis
- Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission
- Efficacy of mizoribine treatment in patients with Sjogren's syndrome : an open pilot trial
- A case report of bilateral hydroureteronephrosis associated with sysytemic sclerosis
- The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8mg/week in patients with rheumatoid arthritis
- Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behcet's disease
- Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept